Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: Best clinical practice guidelines

British Journal of Dermatology

Volumn 174, Issue 1, 2016, Pages 56-67

  Mellerio, J E ^a,b   Robertson, S J ^c   Bernardis, C ^a   Diem, A ^d   Fine, J D ^e   George, R ^a   Goldberg, D ^f   Halmos, G B ^g   Harries, M ^a   Jonkman, M F ^g   Lucky, A ^h   Martinez, A E ^b   Maubec, E ⁱ   Morris, S ^a   Murrell, D F ^j   Palisson, F ^k   Pillay, E I ^a   Robson, A ^a   Salas Alanis, J C ^l   McGrath, J A ^m  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d PARACELSUS MEDICAL UNIVERSITY   (Austria)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MASSACHUSETTS   (United States)

^g UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ AVICENNE HOSPITAL   (France)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

^k UNIVERSIDAD DEL DESARROLLO   (Chile)

^l UNIVERSIDAD DE MONTERREY   (Mexico)

^m ST THOMAS HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID;

AMPUTATION; ANALGESIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL EVALUATION; CONSENSUS; CONSERVATIVE TREATMENT; DISTANT METASTASIS; EPIDERMOLYSIS BULLOSA; HUMAN; LYMPH NODE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIMARY TUMOR; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; SKIN CARCINOMA; SURGICAL WOUND; SYSTEMATIC REVIEW; TERMINAL CARE; TUMOR BIOPSY; WIDE EXCISION; CARCINOMA, SQUAMOUS CELL; COMPLICATION; LIMB PROSTHESIS; LYMPH NODE METASTASIS; METASTASIS; PAIN; PROCEDURES; PSYCHOTHERAPY; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; WOUND CLOSURE;

AMPUTATION; ARTIFICIAL LIMBS; CARCINOMA, SQUAMOUS CELL; CONSENSUS; EPIDERMOLYSIS BULLOSA; HUMANS; LYMPHATIC METASTASIS; MINIMALLY INVASIVE SURGICAL PROCEDURES; NEOPLASM METASTASIS; NEOPLASM STAGING; PAIN; PRACTICE GUIDELINES AS TOPIC; PSYCHOTHERAPY; RETINOIDS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; TERMINAL CARE; WOUND CLOSURE TECHNIQUES;

EID: 84955562538     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.14104     Document Type: Review

References (95)

1. Fine JD, Johnson LB, Weiner M, et al,. Epidermolysis bullosa and the risk of life-threatening cancers: the national EB registry experience, 1986-2006. J Am Acad Dermatol 2009; 60: 203-11.
2. Shivaswamy KN, Sumathy TK, Shyamprasad AL, Ranganathan C,. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl. Int J Dermatol 2009; 48: 731-3.
3. Bosch RJ, Gallardo MA, Ruiz del Portal G, et al,. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients. J Eur Acad Dermatol Venereol 1999; 13: 198-204.
4. Ayman T, Yerebakan Ö, Çiftçioʇlu MA, Alpsoy E,. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma. Pediatr Dermatol 2002; 19: 436-8.
5. Kawasaki H, Sawamura D, Iwao F, et al,. Squamous cell carcinoma developing in a 12-year-old boy with non-Hallopeau-Siemens recessive dystrophic epidermolysis bullosa. Br J Dermatol 2003; 148: 1047-50.
6. Mseddi M, Turki H, Marrekchi S, et al,. Squamous cell carcinoma complicating a hereditary epidermolysis bullosa. Cancer Radiother 2004; 8: 266-9 (in French).
7. Okada T, Sasaki F, Shimizu H, et al,. Effective esophageal balloon dilation for esophageal stenosis in recessive dystrophic epidermolysis bullosa. Eur J Pediatr Surg 2006; 16: 115-19.
8. Chan SM, Dillon MJ, Duffy PG, Atherton DJ,. Nephro-urological complications of epidermolysis bullosa in paediatric patients. Br J Dermatol 2007; 156: 143-7.
9. Dammak A, Zribi J, Boudaya S, et al,. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases. Int J Dermatol 2009; 48: 588-91.
10. Miura K, Umegaki N, Kitaoka T, et al,. A male patient with humoral hypercalcemia of malignancy (HHM) with leukocytosis caused by cutaneous squamous cell carcinoma resulting from recessive dystrophic epidermolysis bullosa. Clin Pediatr Endocrinol 2011; 20: 65-71.
11. McGrath JA, Schofield OM, Mayou BJ, et al,. Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. J Cutan Pathol 1992; 19: 116-23.
12. Mallipeddi R,. Epidermolysis bullosa and cancer. Clin Exp Dermatol 2002; 27: 616-23.
13. Yuen WY, Jonkman MF,. Risk of squamous cell carcinoma in junctional epidermolysis bullosa, non-Herlitz type: report of 7 cases and a review of the literature. J Am Acad Dermatol 2011; 65: 780-9.
14. Reed WB, College J, Francis MJO, et al,. Epidermolysis bullosa dystrophica with epidermal neoplasms. Arch Dermatol 1974; 110: 894-902.
15. Martinez L, Goodman P, Crow WN,. Squamous cell carcinoma of the maxillary sinus and palate in epidermolysis bullosa: CT demonstration. J Comput Assist Tomogr 1992; 16: 317-19.
16. Perez-Naranjo L, Herrera-Saval A, Garcia-Bravo B, et al,. Sentinel lymph node biopsy in recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Arch Dermatol 2005; 141: 110-11.
17. Reed WB, Torres-Rodriguez V, Francis MJO, et al,. Dystrophic epidermolysis bullosa with epidermal neoplasms with emphasis on a dermal collagen defect. Birth Defects Orig Artic Ser 1975; 11: 153-66.
18. Schwartz RA, Birnkrant AP, Rubenstein DJ, et al,. Squamous cell carcinoma in dominant type epidermolysis bullosa dystrophica. Cancer 1981; 47: 615-20.
19. McGrath JA, Schofield OMV, Mayou BJ, et al,. Metastatic squamous cell carcinoma resembling angiosarcoma complicating dystrophic epidermolysis bullosa. Dermatologica 1991; 182: 235-8.
20. Weber F, Bauer JW, Sepp N, et al,. Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa. Acta Derm Venereol 2001; 81: 189-92.
21. Georgeu GA, Ramsey KWD, El-Muttardi N, Mayou BJ,. Groin dissections in epidermolysis bullosa: a report of groin dissection for the control of metastatic squamous carcinoma in patients with epidermolysis bullosa. Br J Plast Surg 2002; 55: 678-99.
22. Mallipeddi R, Keane FM, McGrath JA, et al,. Increased risk of squamous cell carcinoma in junctional epidermolysis bullosa. J Eur Acad Dermatol Venereol 2004; 18: 521-6.
23. Mackie GC, Avram AM,. FDG PET imaging features of epidermolysis bullosa complicated by squamous cell carcinoma. Clin Nucl Med 2005; 30: 69-71.
24. Mohr EB, Lohmeyer JA, Mikhaimer NC, et al,. Multiple squamous cell carcinomas in junctional epidermolysis bullosa: a surgical challenge. Dermatol Surg 2008; 34: 1131-6.
25. Cardin-Langlois E, Hanna D, St-Amant M, Croteau F,. Invasive squamous cell carcinoma of the hand in a patient with Kindler syndrome: case report and literature review. Can J Plast Surg 2010; 18: e41-3.
26. Emanuel PO, Rudikoff D, Phelps RG,. Aggressive squamous cell carcinoma in Kindler syndrome. Skinmed 2006; 5: 305-7.
27. Süss A, Sticherling M, Volz A, et al,. Large metastasizing squamous cell carcinoma in epidermolysis bullosa dystrophica Hallopeau-Siemens. J Eur Acad Dermatol Venereol 2007; 21: 539-41.
28. Huang L, Burd A,. Reconstruction in RDEB patients. Ann Plast Surg 2009; 63: 693.
29. Meola S, Olivieri M, Mirabile C, Mastrandrea P,. Anesthetic management for right upper extremity amputation due to recidivous cutaneous carcinoma and acute postoperative pain control in patients affected by epidermolysis bullosa. Minerva Anestesiol 2010; 76: 144-7.
30. Kim M, Li M, Intong LR, et al,. Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. Br J Dermatol 2013; 169: 208-10.
31. Fine JD, Johnson LB, Weiner M, et al,. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin. J Am Acad Dermatol 2004; 50: 563-71.
32. Yamada M, Hatta N, Sogo K, et al,. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica. Dermatol Surg 2004; 30: 1424-9.
33. Rokunohe A, Nakano H, Aizu T, et al,. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa. J Dermatol 2008; 35: 336-40.
34. Keefe M, Wakeel DC,. Death from metastatic, cutaneous squamous cell carcinoma in autosomal recessive dystrophic epidermolysis bullosa despite permanent inpatient care. Dermatologica 1988; 177: 180-4.
35. Swensson O, Christophers E,. Generalized atrophic benign epidermolysis bullosa in 2 siblings complicated by multiple squamous cell carcinomas. Arch Dermatol 1998; 134: 199-203.
36. Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH,. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa. Dermatology 2009; 219: 80-3.
37. Larocca CA, Cordova AC, Price LA, Milner SM,. Squamous cell carcinoma as a complication of epidermolysis bullosa. Am Surg 2012; 78: E418-19.
38. Crikelair GF, Hoehn RJ, Domonkos AN, Binkert B,. Skin homografts in epidermolysis bullosa dystrophica. Plast Reconstr Surg 1970; 46: 89-92.
39. Eastwood DS,. Autografting in the treatment of squamous cell carcinoma in epidermolysis bullosa dystrophica. Plast Reconstr Surg 1972; 49: 93-5.
40. Didolkar MS, Gerner RE, Moore GE,. Epidermolysis bullosa dystrophica and epithelioma of the skin. Cancer 1974; 33: 198-202.
41. Cardoso J, Azevedo J, Lacerda e Costa MH,. Squamous-cell carcinoma in recessive epidermolysis bullosa dystrophica-case report. Cancer 1986; 1986: 61-4.
42. Monk BE, Pembroke AC,. Epidermolysis bullosa with squamous cell carcinoma. Clin Exp Dermatol 1987; 12: 373-4.
43. Pellicano R, Fabrizi G, Cerimele D,. Multiple keratoacanthomas and junctional epidermolysis bullosa. Arch Dermatol 1990; 126: 305-6.
44. Yoshioka K, Kono T, Kitajima J, et al,. Squamous cell carcinoma developing in epidermolysis bullosa dystrophica. Int J Dermatol 1991; 30: 718-21.
45. Newman C, Wagner RF, Tyring SK, Spigel GT,. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa. A report of 4 patients with 17 primary cutaneous malignancies. J Dermatol Surg Oncol 1992; 18: 301-5.
46. Terrill PJ, Mayou BJ, McKee PH, Eady RA,. The surgical management of dystrophic epidermolysis bullosa (excluding the hand). Br J Plast Surg 1992; 45: 426-34.
47. Schreiber MH, Cavallo FM, Dominguez VE, et al,. Esophageal strictures and squamous cell carcinoma of the maxillary sinus and palate in recessive epidermolysis bullosa dystrophica. Radiographics 1992; 1993: 169-71.
48. Ciccarelli AO, Rothaus KO, Carter DM, Lin AN,. Plastic and reconstructive surgery in epidermolysis bullosa: clinical experience with 110 procedures in 25 patients. Ann Plast Surg 1995; 35: 254-61.
49. Van Rengen A, Degreef H,. Epidermolysis bullosa dystrophica of Hallopeau-Siemens and squamous-cell carcinoma: a case report. Dermatology 1996; 192: 418-19.
50. Hosokawa K, Yoshitatsu S, Kakibuchi M, et al,. Simultaneous manifestation of squamous cell carcinoma in identical twins with epidermolysis bullosa. Plast Reconstr Surg 1998; 102: 448-9.
51. Christiano AM, Crollick J, Pincus S, Uitto J,. Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study. Exp Dermatol 1999; 8: 146-52.
52. Csikõs M, Orosz Z, Bottlik G, et al,. Dystrophic epidermolysis bullosa complicated by cutaneous squamous cell carcinoma and pulmonary and renal amyloidosis. Clin Exp Dermatol 2003; 28: 163-6.
53. Kalisiak MS, Edwards D, Lin AN,. Squamous cell carcinoma in recessive dystrophic epidermolysis bullosa, presenting as an ulcer that appears to be filled with granulation tissue. J Cutan Med Surg 2003; 7: 229-31.
54. Kanitakis J, Barthélémy H, Faure M, Claudy A,. Intracellular expression of type VII collagen in squamous cell carcinoma complicating dystrophic epidermolysis bullosa. Br J Dermatol 1997; 137: 310-13.
55. Tomita Y, Sato-Matsumura KC, Sawamura D, et al,. Simultaneous occurrence of three squamous cell carcinomas in a recessive dystrophic epidermolysis bullosa patient. Acta Derm Venereol 2003; 83: 225-6.
56. Ashton GH, McLean WH, South AP, et al,. Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol 2004; 122: 78-83.
57. Dagregorio G, Guillet G,. Artificial skin as a valuable adjunct to surgical treatment of a large squamous cell carcinoma in a patient with epidermolysis bullosa. Dermatol Surg 2005; 31: 474-6.
58. Buonocore SD, Ariyan S,. Cadaveric allograft for wound closure after resection of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: a report of 32 resections and repairs in 2 patients. Ann Plast Surg 2009; 63: 297-9.
59. Huang L, Wong YP, Burd A,. A novel homozygous splice site mutation in COL7A1 in a Chinese patient with severe recessive dystrophic epidermolysis bullosa and squamous cell carcinoma. Int J Dermatol 2011; 50: 52-6.
60. Rodríguez-Lojo R, Fernández-Jorge B, De Andrés A, et al,. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Eur J Dermatol 2011; 21: 302-3.
61. Gipson M,. Squamous cell carcinoma in epidermolysis bullosa dystrophica. Hand 1975; 7: 179-82.
62. Callen JP, Hudson CP,. Bilateral ulcers in a patient with a hereditary bullous dermatosis. Squamous cell carcinoma (SCC) arising in a patient with recessive dystrophic bullous dermatosis. Arch Dermatol 1987; 123: 815-16.
63. Jain SS, De Lisa JA,. Successful prosthetic fitting of a patient with epidermolysis bullosa dystrophica. Am J Phys Med Rahabil 1988; 67: 104-7.
64. Tabas M,. Squamous cell carcinoma and dystrophic epidermolysis bullosa. Epidermolysis Bullosa: a Comprehensive Review of Classification, Management, and Laboratory Studies. Crowthorne: DEBRA, 1990, 161.
65. Chorny JA, Shroyer KR, Golitz LE,. Malignant melanoma and a squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Arch Dermatol 1993; 129: 1212.
66. Bastin KT, Steeves RA, Richards MJ,. Radiation therapy for squamous cell carcinoma in dystrophic epidermolysis bullosa: case reports and literature review. Am J Clin Oncol 1997; 20: 55-8.
67. Schmutz JL, Kue E, Baylac F, et al,. Angiosarcoma complicating Hallopeau-Siemens-type hereditary epidermolysis bullosa. Br J Dermatol 1998; 138: 910-12.
68. Kömürcü M, Bilgin F, Kurt E, Atesalp AS,. Major surgery and anesthetic technique in epidermolysis bullosa. Mil Med 2004; 169: 125-7.
69. Nair CK, Preethi TR, Somanathan T, Pandey M,. Squamous cell carcinoma in epidermolysis bullosa. Int J Low Extrem Wounds 2004; 3: 100-2.
70. Haruyama T, Furukawa M, Matsumoto F, et al,. Laryngeal stenosis in epidermolysis bullosa dystrophica. Auris Nasus Larynx 2009; 36: 106-9.
71. Edland RW,. Dystrophic epidermolysis bullosa. Tolerance of the bed and response of multifocal squamous cell carcinomas to ionizing radiation: report of a case. Am J Roentgenol Radium Ther Nucl Med 1969; 105: 644-7.
72. Song IC, Dicksheet S,. Management of squamous cell carcinoma in a patient with dominant-type epidermolysis bullosa dystrophica: a surgical challenge. Plast Reconstr Surg 1985; 75: 732-6.
73. Whitney TM, Ramasastry S, Futrell JW,. Combined tissue expansion and free tissue transfer for reconstruction of the hand in epidermolysis bullosa-associated malignancy. Ann Plast Surg 1993; 31: 552-5.
74. Hsieh CH, Kuo YR, Huang PH, Jeng SF,. Free anterolateral thigh perforator flap for reconstruction of dystrophic epidermolysis bullosa-associated squamous cell carcinoma in the foot: case report. Ann Plast Surg 2003; 50: 201-3.
75. Saxena A, Lee JB, Humphreys TR,. Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa. Dermatol Surg 2006; 32: 128-34.
76. Lotem M, Raben M, Zeltser R, et al,. Kindler syndrome complicated by squamous cell carcinoma of the hard palate: successful treatment with high-dose radiation therapy and granulocyte-macrophage colony-stimulating factor. Br J Dermatol 2001; 144: 1284-6.
77. Ray A, Bhattacharya S, Kumar A, Bhattacharya K,. Rare occurrence of carcinoma esophagus in a case of epidermolysis bullosa. Indian J Cancer 2009; 46: 72-3.
78. Wechsler HL, Krugh FJ, Domonkos AN, et al,. Polydysplastic epidermolysis bullosa and development of epidermal neoplasms. Arch Dermatol 1970; 102: 374-80.
79. Lentz SR, Raish RJ, Orlowski EP, Marion JM,. Squamous cell carcinoma in epidermolysis bullosa. Treatment with systemic chemotherapy. Cancer 1990; 66: 1276-8.
80. Maiello E, Giuliani F, Gebbia V, et al,. Cetuximab: clinical results in colorectal cancer. Ann Oncol 2007; 18 (Suppl. 6): vi8-10.
81. Sharafinski ME, Ferris RL, Ferrone S, Grandis JR,. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 2010; 32: 1412-21.
82. Frampton JE,. Cetuximab: a review of its use in squamous cell carcinoma of the head and neck. Drugs 2010; 70: 1987-2010.
83. Maubec E, Petrow P, Scheer-Senyarich I, et al,. Phase II study of cetuximab as first-line single drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 2011; 29: 3419-26.
84. Lewis CM, Glisson BS, Feng L, et al,. A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res 2012; 18: 1435-46.
85. Foote MC, McGrath M, Guminski A, et al,. Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Ann Oncol 2014; 25: 2047-52.
86. Souza CS, Felício LB, Bentley MV, et al,. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol 2005; 153: 672-4.
87. Diociaiuti A, Rotunno R, El Hachem M, et al,. Electrochemotherapy, a potential new treatment for management of squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: report of three cases. J Eur Acad Dermatol Venereol 2015; doi: 10.1111/jdv.13116.
88. Olieman AF, Liénard D, Eggermont AM, et al,. Hyperthermic isolated limb perfusion with tumour necrosis factor α, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicentre study. Arch Surg 1999; 134: 303-7.
89. DiGiovanna JJ,. Retinoid chemoprevention in the high-risk patient. J Am Acad Dermatol 1998; 39: S82-5.
90. Evans TR, Kaye SB,. Retinoids: present role and future potential. Br J Cancer 1999; 80: 1-8.
91. Goldschneider KR, Lucky AW,. Pain management in epidermolysis bullosa. Dermatol Clin 2010; 28: 273-82.
92. Goldschneider KR, Good J, Harrop E, et al,. Pain care for patients with epidermolysis bullosa: best care practice guidelines. BMC Med 2014; 12: 178.
93. Watterson G, Howard R, Goldman A,. Peripheral opioids in inflammatory pain. Arch Dis Child 2004; 89: 679-81.
94. Denyer J, Pillay E,. Best practice guidelines for skin and wound care in epidermolysis bullosa. International consensus. Available at: http://www.woundsinternational.com/media/issues/623/files/content-10609.pdf (last accessed 18 August 2015).
95. Abercrombie EM, Mather CA, Hon J, et al,. Recessive dystrophic epidermolysis bullosa. Part 2: care of the adult patient. Br J Nurs 2008; 17:S6, S8, S10 passim.